To identify possible IDH mutation classification errors on the REMBRANDT dataset, we examined abnormally young or long-living predicted IDH-wildtype glioblastomas as well as abnormally old or short-living predicted IDH-mutant astrocytomas. This evidence concerns the gene IDH1 and glioblastoma.